AI Article Synopsis

  • - Renovascular disease negatively affects the ability of mesenchymal stem/stromal cells (MSCs) derived from human adipose tissue to repair ischemic kidneys in mice.
  • - The study hypothesized that changes in the MSC transcriptome due to renovascular disease reduce their effectiveness in kidney repair, impacted by factors like associated atherosclerosis and hypertension.
  • - Healthy MSCs demonstrated beneficial effects on blood pressure and kidney function, while those from patients with renovascular disease did not, indicating a need for interventions like miR-378h modulation to enhance MSC function.

Article Abstract

Key Points: Renovascular disease impairs the capacity of human adipose tissue–derived mesenchymal stem/stromal cells to repair ischemic murine kidneys. miR-378h modulated the capacity of renovascular disease adipose tissue–derived mesenchymal stem/stromal cells to repair ischemic kidneys .

Background: Renovascular disease leads to renal ischemia, hypertension, and eventual kidney failure. Autologous transplantation of adipose tissue–derived mesenchymal stem/stromal cells (MSCs) improves perfusion and oxygenation in stenotic human kidneys, but associated atherosclerosis and hypertension might blunt their effectiveness. We hypothesized that renovascular disease alters the human MSC transcriptome and impairs their reparative potency.

Methods: MSCs were harvested from subcutaneous abdominal fat of patients with renovascular disease and healthy volunteers (=3 each), characterized and subsequently injected (5×10/200 l) into mice 2 weeks after renal artery stenosis or sham surgery (=6/group). Two weeks later, mice underwent imaging and tissue studies. MSCs from healthy volunteers and in those with renovascular disease were also characterized by mRNA/microRNA (miRNA) sequencing. Based on these, MSC proliferation and mitochondrial damage were assessed before and after miRNA modulation and in additional renal artery stenosis mice administered with MSCs from renovascular disease pretreated with miR-378h mimic (=5) or inhibitor (=4).

Results: MSCs engrafted in stenotic mouse kidneys. Healthy volunteer MSCs (but not renovascular disease MSCs) decreased BP, improved serum creatinine levels and stenotic-kidney cortical perfusion and oxygenation, and attenuated peritubular capillary loss, tubular injury, and fibrosis. Genes upregulated in renovascular disease MSCs versus healthy volunteer MSCs were mostly implicated in transcription and cell proliferation, whereas those downregulated encoded mainly mitochondrial proteins. Upregulated miRNAs, including miR-378h, primarily target nuclear-encoded mitochondrial genes, whereas downregulated miRNAs mainly target genes implicated in transcription and cell proliferation. MSC proliferation was similar, but their mitochondrial structure and reparative function both and improved after miR-378h inhibition.

Conclusions: Renovascular disease impaired the reparative capacity of human MSCs, possibly by dysregulating miR-378h that targets mitochondrial genes.

Podcast: This article contains a podcast at https://dts.podtrac.com/redirect.mp3/www.asn-online.org/media/podcast/JASN/2024_08_21_ASN0000000000000440.mp3

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11543019PMC
http://dx.doi.org/10.1681/ASN.0000000000000440DOI Listing

Publication Analysis

Top Keywords

renovascular disease
44
adipose tissue–derived
12
tissue–derived mesenchymal
12
mesenchymal stem/stromal
12
stem/stromal cells
12
renovascular
11
disease
10
mscs
10
capacity human
8
cells repair
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!